All Stories

  1. Mitigating cell lysis in PET hydrolase production: Nuclease supplementation and growth-decoupled co-cultivation enable scalable enzymatic PET recycling
  2. Leaky recombinant expression reveals design constraints of bicistronic synthetic operons in Escherichia coli
  3. Enhanced genetic stability and expression control in growth-decoupled continuous two-stage E. coli fermentations using plasmid-dependent thyA auxotrophic selection
  4. BioProcessNexus: An open-source platform for surrogate techno economic models
  5. Scar-free tag removal by CASPON® enzyme with broad physicochemical stability in biomanufacturing – A case study of five proteins
  6. Residue-Specific Incorporation of Noncanonical Amino Acids in Auxotrophic Hosts: Quo Vadis?
  7. Site-Directed Genome Integration via Recombinase-Mediated Cassette Exchange (RMCE) in Escherichia coli
  8. Aligning fermentation conditions with non-canonical amino acid addition strategy is essential for Nε-((2-azidoethoxy)carbonyl)-L-lysine uptake and incorporation into the target protein
  9. Manufacturing of the highly active thermophile PETases PHL7 and PHL7mut3 using Escherichia coli
  10. Purification of recombinantly produced somatostatin-28 comparing hydrochloric acid and polyethyleneimine as E. coli extraction aids
  11. A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli
  12. Modifications of the 5’ region of the CASPONTM tag’s mRNA further enhance soluble recombinant protein production in Escherichia coli
  13. Understanding the mechanism of polyethyleneimine-mediated cell disintegration and protein extraction in E. coli: The role of floc network formation and PEI molecular weight
  14. RNA-seq reveals multifaceted gene expression response to Fab production in Escherichia coli fed-batch processes with particular focus on ribosome stalling
  15. Antibody fragments functionalized with non-canonical amino acids preserving structure and functionality - A door opener for new biological and therapeutic applications
  16. Polyethyleneimine efficiently extracts recombinant cytoplasmatic green fluorescent protein produced in Escherichia coli with high purity
  17. Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy
  18. Scale‐related process heterogeneities change properties of high‐cell‐density fermentation broths demonstrated with Escherichia coli B and K‐12 strains
  19. Recombinant Peptide Production Softens Escherichia coli Cells and Increases Their Size during C-Limited Fed-Batch Cultivation
  20. Development and Validation of an Artificial Neural-Network-Based Optical Density Soft Sensor for a High-Throughput Fermentation System
  21. Computational fluid dynamics simulation improves the design and characterization of a plug‐flow‐type scale‐down reactor for microbial cultivation processes
  22. CASPON platform technology: Ultrafast circularly permuted caspase-2 cleaves tagged fusion proteins before all 20 natural amino acids at the N-terminus
  23. CRISPRactivation-SMS, a message for PAM sequence independent gene up-regulation in Escherichia coli
  24. A general deep hybrid model for bioreactor systems: Combining first principles with deep neural networks
  25. Strain specific properties of Escherichia coli can prevent non-canonical amino acid misincorporation caused by scale-related process heterogeneities
  26. Model predictive control for steady-state performance in integrated continuous bioprocesses
  27. Fundamental insights in early‐stage inclusion body formation
  28. Fusion Tag Design Influences Soluble Recombinant Protein Production in Escherichia coli
  29. Strain specific properties of Escherichia coli can prevent non-canonical amino acid misincorporation caused by scale-related process heterogeneities
  30. In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in Escherichia coli
  31. Bioprocess characterization of virus‐like particle production with the insect cell baculovirus expression system at nanoparticle level
  32. Interaction of Periplasmic Fab Production and Intracellular Redox Balance in Escherichia coli Affects Product Yield
  33. Model Transferability and Reduced Experimental Burden in Cell Culture Process Development Facilitated by Hybrid Modeling and Intensified Design of Experiments
  34. Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection
  35. Proton-transfer-reaction mass spectrometry (PTR-MS) for online monitoring of glucose depletion and cell concentrations in HEK 293 gene therapy processes
  36. PROFICS: A bacterial selection system for directed evolution of proteases
  37. Stable Sf9 cell pools as a system for rapid HIV‐1 virus‐like particle production
  38. Digital Twin Application for Model-Based DoE to Rapidly Identify Ideal Process Conditions for Space-Time Yield Optimization
  39. High shear resistance of insect cells: the basis for substantial improvements in cell culture process design
  40. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests
  41. Whole cell-based catalyst for enzymatic production of the osmolyte 2-O-α-glucosylglycerol
  42. Native Hydrophobic Interaction Chromatography Hyphenated to Multi-Angle Light Scattering Detection for In-Process Control of SARS-CoV-2 Nucleocapsid Protein Produced in Escherichia Coli
  43. Holistic view on processes is essential for efficient production process development
  44. Tunable expression rate control of a growth-decoupled T7 expression system by l-arabinose only
  45. Three-dimensional chromatography for purification and characterization of antibody fragments and related impurities from Escherichia coli crude extracts
  46. Advanced purification platform using circularly permuted caspase‐2 for affinity fusion‐tag removal to produce native fibroblast growth factor 2
  47. Quantification of glycated IgG in CHO supernatants: A practical approach
  48. High-throughput microbioreactor provides a capable tool for early stage bioprocess development
  49. A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays
  50. Accelerating HIV‐1 VLP production using stable High Five insect cell pools
  51. Reconsider the shear paradigm - stirring and aeration strategies in cell culture processes
  52. Production of Circularly Permuted Caspase-2 for Affinity Fusion-Tag Removal: Cloning, Expression in Escherichia coli, Purification, and Characterization
  53. Adaptive Evolution in Producing Microtiter Cultivations Generates Genetically Stable Escherichia coli Production Hosts for Continuous Bioprocessing
  54. Fast and antibiotic free genome integration into Escherichia coli chromosome
  55. PEI-Mediated Transient Transfection of High Five Cells at Bioreactor Scale for HIV-1 VLP Production
  56. Hybrid Modeling and Intensified DoE: An Approach to Accelerate Upstream Process Characterization
  57. Bacteriophage Inspired Growth-Decoupled Recombinant Protein Production in Escherichia coli
  58. Extraction of recombinant periplasmic proteins under industrially relevant process conditions: Selectivity and yield strongly depend on protein titer and methodology
  59. Escherichia coli σ70 promoters allow expression rate control at the cellular level in genome-integrated expression systems
  60. Comparison of Modeling Methods for DoE‐Based Holistic Upstream Process Characterization
  61. Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells
  62. Soft sensor based on 2D‐fluorescence and process data enabling real‐time estimation of biomass in Escherichia coli cultivations
  63. The shortcomings of accurate rate estimations in cultivation processes and a solution for precise and robust process modeling
  64. Oxygen Uptake Rate Soft-Sensing via Dynamic kLa Computation: Cell Volume and Metabolic Transition Prediction in Mammalian Bioprocesses
  65. Impact of mammalian cell culture conditions on monoclonal antibody charge heterogeneity: an accessory monitoring tool for process development
  66. Microbioreactor Cultivations of Fab‐Producing Escherichia coli Reveal Genome‐Integrated Systems as Suitable for Prospective Studies on Direct Fab Expression Effects
  67. Implementation of a Fully Automated Microbial Cultivation Platform for Strain and Process Screening
  68. Lectin bio‐layer interferometry for assessing product quality of Fc‐ glycosylated immunoglobulin G
  69. Application of the Bradford Assay for Cell Lysis Quantification: Residual Protein Content in Cell Culture Supernatants
  70. Quality by control: Towards model predictive control of mammalian cell culture bioprocesses
  71. High-level biosynthesis of norleucine in E. coli for the economic labeling of proteins
  72. Boosted structured additive regression forEscherichia colifed-batch fermentation modeling
  73. Process limitations of a whole-cell P450 catalyzed reaction using a CYP153A-CPR fusion construct expressed in Escherichia coli
  74. Fed-batch like cultivation in a micro-bioreactor: screening conditions relevant for Escherichia coli based production processes
  75. The potential of random forest and neural networks for biomass and recombinant protein modeling inEscherichia colifed-batch fermentations
  76. Finished Genome Sequence of the Laboratory Strain Escherichia coli K-12 RV308 (ATCC 31608)
  77. Finished Genome Sequence of Escherichia coli K-12 Strain HMS174 (ATCC 47011)
  78. Online prediction of product titer and solubility of recombinant proteins in Escherichia colifed-batch cultivations
  79. Preventing T7 RNA Polymerase Read-through Transcription—A Synthetic Termination Signal Capable of Improving Bioprocess Stability
  80. A Comparative Analysis of Industrial Escherichia coli K–12 and B Strains in High-Glucose Batch Cultivations on Process-, Transcriptome- and Proteome Level
  81. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production
  82. Comparative Transcription Profiling and In-Depth Characterization of Plasmid-Based and Plasmid-Free Escherichia coli Expression Systems under Production Conditions
  83. A sequence comparison and gene expression data integration add-on for the Pathway Tools software
  84. Implementation of proton transfer reaction-mass spectrometry (PTR-MS) for advanced bioprocess monitoring
  85. Soft sensors in bioprocessing: A status report and recommendations
  86. An Advanced Monitoring Platform for Rational Design of Recombinant Processes
  87. Process analytical technology (PAT) for biopharmaceuticals
  88. Marker-free plasmids for gene therapeutic applications—Lack of antibiotic resistance gene substantially improves the manufacturing process
  89. Plasmid-free T7-basedEscherichia coliexpression systems
  90. Interactive visualization of clusters in microarray data: an efficient tool for improved metabolic analysis of E. coli
  91. Model-based probe set optimization for high-performance microarrays
  92. Influence of process temperature on recombinant enzyme activity in Escherichia coli fed-batch cultures
  93. Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli
  94. Npro fusion technology to produce proteins with authentic N termini in E. coli
  95. Using ColE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system
  96. Evaluation of the GFP signal and its aptitude for novel on-line monitoring strategies of recombinant fermentation processes
  97. Tuning the Transcription Rate of Recombinant Protein in Strong Escherichia coli Expression Systems through Repressor Titration
  98. Stabilizing plasmid copy number to improve recombinant protein production
  99. Non-invasive detection of the metabolic burden on recombinant microorganisms during fermentation processes
  100. Recombinant Expression of Alliin Lyase from Garlic (Allium sativum) in Bacteria and Yeasts